A Case Report of a Severely Immunocompromised Patient with Clinically Amyopathic Dermatomyositis-related ILD: Is CMV-prevention Indicated?

Autor: Mohamed Hoesein Faa, Bernhard Ae, Verduyn Luynel Fm, Kwakkel-van Erp Jm, Voortman M, Leavis Hl

Publikováno v: Journal of pulmonary & respiratory medicine

We herein report a case of a 59-year old female with rapidly progressive interstitial lung disease due to antiMDA-5 positive clinically amyopathic dermatomyositis. Despite initial response to a combination high dose immunosuppressive treatment, her r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1f6b347e506151a1959969880fb6c7b
https://doi.org/10.4172/2161-105x.1000480

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus.

Autor: Kaan ED; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Brunekreef TE; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Drylewicz J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van den Hoogen LL; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van der Linden M; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Leavis HL; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Laar JM; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van der Vlist M; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Otten HG; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Limper M; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Publikováno v: Journal of translational autoimmunity [J Transl Autoimmun] 2024 Jun 20; Vol. 9, pp. 100246. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).

Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts.

Autor: Leavis HL; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands., van Daele PLA; Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands., Mulders-Manders C; Department of Internal medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Michels R; IQVIA, Amsterdam, The Netherlands., Rutgers A; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands., Legger E; Department of Pediatric Rheumatology, University Medical Center Groningen, Groningen, The Netherlands., Bijl M; Department of Rheumatology and Clinical Immunology, Martini Hospital, Groningen, The Netherlands., Hak EA; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Lam-Tse WK; Department Rheumatology, Franciscus Hospital, Rotterdam, The Netherlands., Bonte-Mineur F; Department of Rheumatology and Clinical Immunology, Maasstad Hospital, Rotterdam, The Netherlands., Fretter P; Department of Rheumatology, Treant Hospitals, Emmen/Hoogeveen/Stadskanaal, The Netherlands., Simon A; Department of Internal medicine, Radboud University Medical Center, Nijmegen, The Netherlands., van Paassen P; Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands., van der Goes MC; Department of Rheumatology, Meander Medical Center, Amersfoort, The Netherlands., Flendrie M; Department of Rheumatology, Maartenskliniek, Nijmegen, The Netherlands., Vercoutere W; Department of Rheumatology, Reumazorg Zuid-West Nederland, Goes-Terneuzen-Oostburg, The Netherlands., van Lieshout AWT; Department of Rheumatology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands., Leek A; Department of Pediatrics, University Medical Center Utrecht, Utrecht, The Netherlands., Vastert SJ; Department of Pediatrics, University Medical Center Utrecht, Utrecht, The Netherlands., Tas SW; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 03; Vol. 63 (6), pp. 1656-1663.

Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study.

Autor: Verschoof MA; Department of Neurology, HagaZiekenhuis, The Hague, The Netherlands., van Meenen LCC; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Andriessen MVE; Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands., Brinkman DMC; Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands., Kamphuis S; Department of Pediatric Rheumatology, Sophia Children's Hospital, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Kuijpers TW; Department of Pediatric Immunology and Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Leavis HL; Department of Rheumatology and Clinical Immunology, University Medical Center and Utrecht University, Utrecht, The Netherlands., Legger GE; Department of Pediatric Rheumatology and Immunology, University Groningen, University Medical Center Groningen, Groningen, The Netherlands., Mulders-Manders CM; Department of Internal Medicine, Radboud Expertise Center for Immunodeficiency and Autoinflammation, Radboud University Medical Center, Nijmegen, The Netherlands., de Pagter APJ; Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands., Rutgers A; Department of Rheumatology and Clinical Immunology, University Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Well GTJ; Division of Pediatric Infectious Diseases, Immunology & Rheumatology, Department of Pediatrics, Maastricht University Medical Center, Maastricht, The Netherlands., Coutinho JM; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Hak AE; Departments of Internal Medicine and Rheumatology and Clinical Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Montfrans JM; Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands., Klouwer FCC; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pediatric Neurology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: European journal of neurology [Eur J Neurol] 2024 Jan; Vol. 31 (1), pp. e16043. Date of Electronic Publication: 2023 Aug 29.